For Immediate Release:

Enzymatic Therapy® Launches Breakthrough Product for Digestive Predictability

Over 95% Relief of Common Digestive Symptoms!†

GREEN BAY, WISCONSIN (November 20, 2008) – The American College of Gastroenterology estimates that nearly 58 million people are searching for digestive predictability. Enzymatic Therapy, the manufacturer and distributor of over 200 nutritional supplements and natural medicines, has launched a natural solution to provide the relief so many are looking for – PredictEase™ intestinal balancing system.†

PredictEase helps individuals regain control of their digestion by providing relief of episodic cramps, bloating, constipation and loose stools.† This breakthrough formula contains fiber to regulate healthy bowel function, probiotics to replenish beneficial microflora and melatonin to restore intestinal motility.†

A clinical study found that the combined effects of the fiber, probiotics and melatonin featured in PredictEase quickly restored and helped maintain healthy intestinal function.† From start to finish, individuals reported over 95% relief of common gastrointestinal symptoms, as well as an 82% improvement in abdominal discomfort and 64% more comfort during bowel movements.† This unique formulation is the solution for anyone seeking digestive predictability.†

PredictEase is the newest addition to Enzymatic Therapy’s successful line of natural health products, and is available at health food retailers nationwide. For more information, visit www.predictease.com.

For nearly 30 years, Enzymatic Therapy, Inc., (ETI) based in Green Bay, Wisconsin, has been North America’s leading manufacturer and distributor of dietary supplements and natural medicines. ETI is an FDA-registered drug establishment and also a certified organic processor. It was the first company to introduce standardized Ginkgo biloba, glucosamine sulfate and botanical standardization to the United States health market. The company’s products and ingredients are collectively the subject of over 2,500 independent, peer-reviewed-published clinical trials and studies. For more information, visit www.enzymatictherapy.com.